Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation
- 1 August 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 270 (2), 302-308
- https://doi.org/10.1097/sla.0000000000002789
Abstract
Objective: To report 1-year results from a 5-year mandated study. Summary Background Data: In 2012, the United States Food and Drug Administration approved magnetic sphincter augmentation (MSA) with the LINX Reflux Management System (Torax Medical, Shoreview, MN), a novel device for the surgical treatment of gastroesophageal reflux disease (GERD). Continued assessment of safety and effectiveness has been monitored in a Post Approval Study. Methods: Multicenter, prospective study of patients with pathologic acid reflux confirmed by esophageal pH testing undergoing MSA. Predefined clinical outcomes were assessed at the annual visit including a validated, disease-specific questionnaire, esophagogastricduodenoscopy and esophageal pH monitoring, and use of proton pump inhibitors. Results: A total of 200 patients (102 males, 98 females) with a mean age of 48.5 years (range 19.7–71.6) were treated with MSA between March 2013 and August 2015. At 1 year, the mean total acid exposure time decreased from 10.0% at baseline to 3.6%, and 74.4% of patients had normal esophageal acid exposure time (% time pH<4 ≤5.3%). GERD Health-Related Quality of Life scores improved from a median score of 26.0 at baseline to 4.0 at 1 year, with 84% of patients meeting the predefined success criteria of at least a 50% reduction in total GERD Health-Related Quality of Life score compared with baseline. The device removal rate at 1 year was 2.5%. One erosion and no serious adverse events were reported. Conclusions: Safety and effectiveness of magnetic sphincter augmentation has been demonstrated outside of an investigational setting to further confirm MSA as treatment for GERD.Keywords
This publication has 29 references indexed in Scilit:
- Esophageal Sphincter Device for Gastroesophageal Reflux DiseaseThe New England Journal of Medicine, 2013
- Potentially Reversible Pseudoachalasia After Laparoscopic Adjustable Gastric BandingJournal of Clinical Gastroenterology, 2011
- Esophageal Dysmotility Disorders After Laparoscopic Gastric Banding—An Underestimated ComplicationAnnals of Surgery, 2011
- Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care SurveyDigestive Diseases and Sciences, 2009
- Gastroesophageal Reflux DiseaseThe New England Journal of Medicine, 2008
- Secondary Achalasia and Other Esophageal Motility Disorders After Laparoscopic Nissen Fundoplication for Gastroesophageal Reflux DiseaseAmerican Journal of Roentgenology, 2007
- Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motilitySurgical Endoscopy, 2007
- Nissen Fundoplication for Gastroesophageal Reflux DiseaseAnnals of Surgery, 1986
- Evaluation of Angelchik antireflux prosthesisDigestive Diseases and Sciences, 1985